Anne Marie de Jonge Schuermans
Net worth: - $ as of 2024-03-30
Profile
Presently, Anne Marie de Jonge Schuermans is Head-Technical Operations at Swedish Orphan Biovitrum AB. She previously held the position of Member-Executive Board at Biogen International GmbH. She received a graduate degree from École Polytechnique Fédérale de Lausanne, a doctorate from Swiss Federal Institute of Technology and a graduate degree from Wageningen University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PHARVARIS N.V.
-.--% | 2023-03-09 | 0 ( -.--% ) | - $ | 2024-03-30 |
Former positions of Anne Marie de Jonge Schuermans
| Companies | Position | End |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Chief Tech/Sci/R&D Officer | 2021-12-31 |
Biogen International GmbH
 Biogen International GmbH Pharmaceuticals: MajorHealth Technology Biogen International GmbH produces pharmaceuticals. It develops medicines for psoriasis and multiple sclerosis. Its products include FUMADERM and BG-12. The company was founded in 1983 and is headquartered in Lucerne, Switzerland. | Corporate Officer/Principal | 2018-09-30 |
| PHARVARIS N.V. | Director/Board Member | - |
Training of Anne Marie de Jonge Schuermans
| École Polytechnique Fédérale de Lausanne | Graduate Degree |
| Swiss Federal Institute of Technology | Doctorate Degree |
| Wageningen University | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| PHARVARIS N.V. | Health Technology |
| Private companies | 1 |
|---|---|
Biogen International GmbH
Biogen International GmbH Pharmaceuticals: MajorHealth Technology Biogen International GmbH produces pharmaceuticals. It develops medicines for psoriasis and multiple sclerosis. Its products include FUMADERM and BG-12. The company was founded in 1983 and is headquartered in Lucerne, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Anne Marie de Jonge Schuermans
